CLINICAL
GENE TRANSFER SUBCOMMITTEE
OF THE INSTITUTIONAL BIOSAFETY COMMITTEE
The Clinical Gene Transfer Subcommittee (CGTS) of the Dartmouth Institutional
Biosafety Committee (IBC) is a multidisciplinary committee charged with the review
of clinical protocols involving gene transfer as defined in the NIH GUIDELINES
FOR RESEARCH INVOLVING RECOMBINANT DNA MOLECULES (latest edition). This will include:
(1) peer review of the scientific merit of each clinical gene transfer protocol;
(2) review of the protocol for concerns to safety and (3) review to determine
whether all appropriate regulatory requirements have been fulfilled prior to initiation
of the protocol. The CGTS has the authority to approve, require modifications
in, or disapprove all research activities that fall within its purview. This committee
advises the IBC and the Institutional Review Board (IRB) on the science and safety
of the proposed protocols. Click here to
view a copy the information required for submitting a protocol.
Clinical Gene Transfer Subcommittee Members:
Christopher Lowrey, MD |
Subcommittee Chair/MedicineHematology/Oncology |
Elizabeth Bankert, MA |
Assistant Provost/Human Subjects Protection Official |
Michael Blayney, Ph.D. |
Director, Environmental Health & Safety |
Robert Enos, RPh., MBA |
Research Pharmacy |
Lionel Lewis, BCH, MD |
Medicine/ Pharmacology & Toxicology |
Tim Lahey, MD |
Medicine/ Infectious Diseases |
Robert McLellan, MD, MPH |
Medicine/Occupational Medicine |
Nancy Crosby, MSN, ARNP |
Medicine/Hematology/Oncology |
Richard Powell, MD |
Medicine/Vascular Surgery |
Eric Cook, MPH |
Biological Safety Officer |
|
